Crypto
Bitcoin Surges to Record High Amid “Uptober” Rally and Strong ETF Inflows
Bitcoin hit a new all-time high of $125,500, confirming “Uptober” momentum as ETFs saw strong inflows—$3.24 billion for BTC and $1.3 billion for ETH. BNB reached $1,190, while Solana rose 12%. Despite U.S. political gridlock, sentiment remains bullish. Analysts target $130,000, supported by possible rate cuts, though global conflicts pose market risks.

Bitcoin traded at $125,500 on Sunday, about $1,000 higher than its previous record high in mid-August. Ethereum, BNB, Solana, and others are also performing well in this environment.
With a new all-time high of around $125,500 on Sunday, Bitcoin confirmed October’s reputation for consistently delivering gains for BTC. This is why October is often called “Uptober” in the crypto scene. Binance Coin (BNB) also recorded a new all-time high of $1,190 over the weekend, while other popular altcoins like Ethereum and Solana gained 10 percent or more in the first few days of October. What will shape Bitcoin and other cryptocurrencies this trading week?
In the US, there is no end in sight to the shutdown, and negotiations appear to be at a standstill. However, fears that the shutdown could harm BTC’s price performance are not coming true – quite the opposite. Analysts like Jeff Dorman of the investment firm Arca even see the shutdown and domestic political dispute as a positive for Bitcoin. “I only buy BTC at times when society is losing trust in governments and banks,” Dorman writes on X.
Bitcoin ETFs back on record course
Bitcoin ETFs in the US are highlighted as a direct price driver. With $3.24 billion in capital inflows, Bitcoin ETFs experienced their second-best performance since their inception last week, according to data from SoSo.
Ethereum ETFs also enjoyed a capital inflow of $1.3 billion, and ETH is now trading at a promising level of just over $4,500. Solana climbed to just over $230 with a weekly gain of 12 percent, also a potential launching pad for further gains.
ASTER DEX again confronted with allegations of manipulated data
There’s a lot of excitement surrounding ASTER, the challenger to Hyperliquid (HYPE) launched in September. The data service DeFiLlama has refrained from publishing figures on Aster’s derivatives trading volumes until further notice.
DeFiLlama co-founder 0xngmi explained the decision to move to X by arguing that Aster is likely engaging in wash trading, i.e., artificially inflating trading volumes. As early as the end of September, serious doubts about Aster’s data were circulating, and the DEX was at risk of losing confidence.
Conclusion: Bitcoin leads crypto markets into “Uptober”
Optimists are now setting $130,000 as Bitcoin ‘s next price target and will closely monitor whether the ETFs have another strong week. In the background, a cut in the US key interest rate expected at the end of October continues to boost sentiment, as such a move typically favors Bitcoin.
BNB, Solana, and Ethereum, as leading altcoins in the decentralized finance (DeFi) sector, are gaining momentum in Bitcoin’s wake – October rallies would be no surprise. The military conflicts in Ukraine and the Gaza Strip could prove to be a damper on the fun; escalation would not be in the best interests of the financial markets or Bitcoin.
__
(Featured image by Kanchanara via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in BLCOK-BUILDERS.DE. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

-
Biotech1 week ago
SEMG Launches Diabetosemg 2025 Algorithm for Personalized Diabetes Care
-
Biotech2 weeks ago
Navarre Opens Strategic Health Research Plan for Public Participation
-
Biotech4 days ago
Foreomics Launches First Tool Predicting Mortality and Illness Risks
-
Business2 weeks ago
Trump Appoints Miran as Fed Dissenter, Pushes for Aggressive Rate Cuts and Fed Reshaping